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Background: Studies have shown the roles of miR-9 and its validated target, protogenin (PRTG) in the
differentiation of chondroblasts to chondrocyte and in the pathogenesis of osteoarthritis (OA). We hypothesized
that miR-9 plays a distinct role in endochondral ossification and OA pathogenesis and the present study was
undertaken to identify this role. In the studies, chondroblasts were isolated from limb bud of chick and mouse
embryos and articular chondrocytes were isolated from rabbit and human cartilage. Osteoarthritic chondrocytes
were isolated from cartilage from patients undergoing total knee replacement. Using these cells, we analyzed the
changes in the expression of genes and proteins, tested the expression level of miR-9, and applied a target
validation system. We also performed functional study of miR-9 and PRTG.
Results: With the progression of chondrogenesis, decreased miR-9 level was observed at the time of numerous
apoptotic cell deaths. And chondrocytes isolated from normal human articular cartilage expressed miR-9, and this
expression was significantly reduced in OA chondrocytes, especially decreased its expression in parallel with the
degree of cartilage degradation. Over-expression of PRTG induced the activation of caspase-3 signaling and
increased apoptosis. However, the co-treatment with the miR-9 precursor or PRTG-specific siRNA blocked this
apoptotic signaling.
Conclusion: This study shows that PRTG is regulated by miR-9, plays an inhibitory action on survival of
chondroblasts and articular chondrocytes during chondrogenesis and OA pathogenesis.
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Chondrogenesis is the earliest phase of skeletal develop-
ment. Most long bones of vertebrates are formed through
the process of endochondral ossification. This well-defined
and coordinated process involves mesenchymal cell
condensation and chondrogenic differentiation for proper
cartilage and bone formation [1]. Several reports have
shown that two MAPKs, ERK and p38MAPK, regulate
chondrogenesis [2,3]. However, despite the importance of
these MAPKs in the regulation of cartilage formation,
relatively little is known about the involvement of another
MAPK signaling pathway, c-jun N-terminal kinase (JNK).
Several recent studies demonstrated the importance of
JNK signaling during chondrogenesis [4-11]. Activin-A, a* Correspondence: jineunjung@wku.ac.kr
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reproduction in any medium, provided the ormember of the transforming growth factor-β family, may
suppress chondrocyte differentiation in ATDC5 cells
via down-regulation of JNK [4] and reverse signaling of
ephrin-B inhibited the attachment and migration of
human mesenchymal cells by activating JNK signaling
during osteochondral differentiation [5]. Furthermore, in
adult articular chondrocytes, MAPK activation is known
to associate matrix metalloproteinases (MMPs). Inhibition
of JNK signaling inhibits fibronectin fragment stimulation
of MMP-13 expression [6,7] and IL-1 stimulation of
MMP-13 requires JNK signaling [8]. Our laboratory also
showed that JNK signaling is involved in the differentiation
of chondroprogenitors in chicks through regulation of
miR-34a [9,10] and miR-221 levels [11].
Several reports have suggested a possible role of miRNAs
in limb development. In dicer-null mice, a reduced prolifer-
ating pool of chondrocytes was observed, and this reduction
resulted in severe skeletal growth defects and premature
death in the mice [12]. Furthermore, expression of severaltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the developing limb and found to be involved in the
specification of limb development [13,14]. However, the
precise roles of miRNAs in limb development have not
yet been fully established.
Protogenin (PRTG) belongs to the immunoglobulin
superfamily and is most closely related to the deleted in
colorectal cancer (DCC)-Neogenin subclass [15], which, in
addition to DCC and Neogenin, includes Punc and Nope.
Recent study showed that PRTG have two proteolytic
cleavages. One is between the fibronectin III and the
transmembrane domain for ectodomain-shedding, another
is by γ-secretase at the interface of the transmembrane and
the intracellular domain to release C-terminal intracellular
domain of PRTG. This released C-terminal intracellular
domain can translocate to the nucleus to regulate neuronal
differentiation [16]. PRTG functions as a receptor to
prevent precocious neuronal differentiation in neural
progenitors [17] and plays a role in the rearrangement of
cells of the paraxial mesodermal lineage [18]. Recently, the
expression pattern of PRTG in mouse embryos has been
published [19]. As in mouse embryos, PRTG became
progressively restricted dorsally in the spinal cord with
highest level in the roof plate anterior to the forelimb,
suggesting a role during avian limb development. Although
several studies emphasize the importance of PRTG during
development of various tissues, neither a specific role nor
the molecular mechanisms of PRTG action during limb
development have been determined. The factors respon-
sible for PRTG regulation are also still unknown. Here,
for the first time, we found that PRTG exhibits chondro-
inhibitory action in limb mesenchymal cells and that
PRTG is a direct target of miR-9.
Results
MiR-9 induces chondro-inhibitory action during
chondrogenic differentiation of chick limb
mesenchymal cells
From previously reported miRNA array data by inhib-
ition of JNK signaling [11], we identified 14 up-regulated
miRNAs and 12 down-regulated miRNAs whose expres-
sions were altered during chondrogenesis (Additional
file 1). Among them, miR-9 was one of miRNA whose
expression was substantially altered with inhibition of
chondrogenic differentiation (determined using a P-value
of 0.01 as a cutoff for significance). Inhibition of JNK
signaling did not affect other signaling, including Akt
and GSK, as confirmed by immunoblotting (Figure 1A).
Down-regulation of miR-9 by blockade of JNK signaling
was confirmed by quantitative RT-PCR (Figure 1B).
In order to examine the involvement of miR-9 during
chondrogenesis, we exposed mesenchymal cells to 200
nM peptide nucleic acid-based antisense oligonucleotides
(ASOs) against miR-9 (miR-9 inhibitor) whose knockdownefficiency was monitored by real time PCR (Figure 1C,
upper panel). Precartilage condensation and chondrogenic
differentiation were assessed by PA at day 3 and Alcian blue
staining at day 5, respectively. Decreased intensities of PA
at day 3 and Alcian blue staining at day 5 were observed
with treatment of anti-miR-9 oligonucleotides (Figure 1C,
lower panel). Treatment of cells with a miR-9 inhibitor
caused a significant decrease in total cell numbers
(Figure 1D) with significant increases in apoptotic cell
death (Figure 1E) and caspase-3 activity (Figure 1F). Our
results revealed that miR-9 inhibitor-induced apoptotic
cell death may be responsible for JNK blockade-induced
chondro-inhibitory action on precartilage condensation.
MiR-9 stimulated chondrogenic differentiation by
regulating protogenin
Target genes of miR-9 were predicted using miRNA target
prediction algorithms, including TargetScan and miRDB
and PRTG was identified as a potential target. In support
of this prediction, we observed a significant induction
in PRTG protein level in miR-9 inhibitor-treated or JNK
inhibitor-treated chondroprogenitor cells. And increased
protein level of PRTG by JNK inhibitor treatment was
significantly reduced with co-introduction of miR-9
(Figure 2A). To confirm that PRTG is a target for miR-9,
we cloned the entire 3′ UTR of PRTG into a luciferase re-
porter vector, electroporated the vector into chondrogenic
progenitors along with the precursor of miR-9 or a
cognate non-targeting negative control, and assayed
cell lysates for luciferase expression. We found that cells
transfected with the PRTG-3′ UTR vector plus miR-9
exhibited significantly less luciferase activity compared
to cells that received the vector plus the non-targeting
negative control (Figure 2B). Seed sequences of putative
targets for miR-9 (Figure 2B upper panel) were exchanged
a purine for a pyrimidine and a pyrimidine to a purine.
Luciferease activity was not affected with these mutated
constructs. Induction of miR-9 successfully reduced
PRTG protein level in myc-tagged PRTG/pCAGGS vector
electroporated cells (Figure 2C).
To investigate temporal and spatial expression of PRTG,
micromass cultures were sectioned longitudinally and
immunostained with PRTG antibody (Figure 2E). The
RNA level of PRTG was also significantly decreased at
3, 6, and 9 days of culture i.e. at the time of proliferation
and condensation with increased expression level of
miR-9 and significantly increased at 12, 15, and 18 days
of culture, i.e. at the time of hypertrophy and apoptosis
with a decreased expression level of miR-9 (Figure 2F).
MiR-9 protects PRTG-induced apoptosis of
chondroprogenitors during chondrogenesis
To observe the effects of PRTG, chondroblasts were
electroporated with the myc-tagged PRTG/pCAGGS
Figure 1 MiR-9 affects cell proliferation and survival during chondrogenesis of chick limb mesenchymal cells. (A) Changes in the
phosphorylation levels of Akt, GSK, and JNK were analyzed by Western blotting. (B) Total RNA was purified from chondroprogenitors cultured
with or without 5 μM JNK inhibitor and the expression of mir-9 was measured with real-time PCR. (C) Chondroprogenitor cells were treated with
100 nM of anti-mir-9 oligonucleotides (mir-9inhibitor). The expression of mir-9 was measured with real-time PCR (upper panel) and Precartilage
condensation was analyzed by PA staining at day 3 and Alcian blue staining at day 5 of culture (lower panel). The data shown are representative
of at least four independent experiments. The diameter of typical standard culture is 5 mm. (D) Total cell numbers were counted at 2 day of
culture. (E) Apoptotic cells were analyzed by FACS analysis. (F) Changes in the cleaved form of caspase-3 were analyzed by Western blotting.
Results of cell adhesion experiments were pooled from 5 replicate samples derived from 4 independent experiments. The mean is plotted and
the error bars represent 95% CI (lower/upper limit). ***, statistically different from control cells (p < 0.001).
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immunoblotting (Figure 3A left upper panel). Precartilage
condensation markedly decreases in response to PRTG
over-expression (Figure 3A left lower panel). When the
micromass cultures were stained with Alcian blue, the
number and size of individual cartilage nodules (Figure 3A
left lower panel) and staining intensities (Figure 3A right
panel) were also noticeably decreased in response to PRTG
over-expression. And these inhibitory actions of PRTG on
precartilage condensation and chondrogenic differentiation
were recovered by co-introduction of miR-9. These data
suggested that miR-9 suppresses sulfated proteoglycan
accumulation and cartilage nodule formation for chondro-
genic differentiation possibly by targeting PRTG.
Since condensation could be due to the modulation of
cell number, we next examined whether PRTG suppresses
precartilage condensation and chondrogenic differentiation
through regulation of cell proliferation or survival. Consist-
ent with suppression of chondrogenesis, cell proliferation
was significantly decreased in PRTG over-expressed cells
(Figure 3B left panel). Furthermore, decreased in total
cell number by JNK inhibitor or PRTG was reversed by
co-introduction of PRTG siRNA or miR-9, respectively
(Figure 3B, right panel). Apoptotic cell death, as assessed
by FACS analysis (left panel) and by caspase-3 activity
(right panel), was increased by the introduction of PRTG or
treatment of JNK inhibitor and inhibited by co-induction
of miR-9 (Figure 3C). As well, inhibited precartilage con-
densation by JNK inhibition and PRTG over-expression
was recovered by co-electroporation of PRTG-specific
siRNA or co-introduction of miR-9 (Figure 3D) confirmedits efficiency with PRTG over-expressed cells (Figure 3C
lower panel).
To further investigate miR-9 involvement in limb
formation, 18 HH stage chick embryos were treated
with JNK inhibitor in the absence or presence of miR-9
inhibitors. We observed the disruption of limb forma-
tion, especially formation of inter-digital regions, in JNK
inhibitor-treated chick embryos. This malformation was
overcome by co-treatment of miR-9 inhibitor (Figure 3E).
These results indicate that negative regulation of chondro-
genesis by the over-expression of PRTG is mediated by
modulating apoptotic death of chondrogenic competent
cells.
MiR-9 also protects PRTG-induced apoptosis
of chondrocytes
In order to further study the role of miR-9 in survival of
chondrocytes, dedifferentiation of articular chondrocytes
was induced by IL-1β exposure. We confirmed that IL-1β
exposure to cells decreased the expression level of miR-9
(Figure 4A). It has been shown that differentiated
chondrocytes could lose their intrinsic characteristics
upon exposure to IL-1β [20,21], nitric oxide [22], or
retinoic acid [23,24], and during serial monolayer culture
[25,26] through a process designated “dedifferentiation”.
Dedifferentiation was confirmed by a degenerated morph-
ology (Figure 4B and 4C upper panel). A more significant
degenerative phenotype and decreased level of type II
collagen were observed in co-treatment of miR-9 inhibitor
with IL-1β (Figure 4B) and IL-1β-induced degenerative
changes were prevented by co-introduction of miR-9
Figure 2 miR-9 targets PRTG and inhibits chondrogenic differentiation. (A) Cells were cultured at a density of 2 × 107 cells/ml and treated
with miR-inhibitor, JNK inhibitor or in the combination of JNK inhibitor and miR-9 precursor (miR-9). Changes in the protein level of PRTG were
analyzed at day 2 of culture. (B) Luciferase reporter gene assays of cells expressing the construct containing the human PRTG-3′-UTR or mutated
seed sequence (mut 2436–2465, mut3067-3102) of putative targets (upper panel) in the absence or presence of miR-9. (C) Cells were
electroporated with PRTG, incubated with either miR-9 precursor or miR-9 inhibitor, and changes in the protein level of PRTG were analyzed at
day 2 of culture. (D) Mouse chondrogenitors were cultured at a density of 2 × 107 cells/ml, sectioned, and stained with anti-PRTG antibody at day
6, 9, 12, 15, 18, 21 days of culture. (E) The expressions of PRTG, type X collagen (Col X), and miR-9 were measured with real-time PCR. Apoptotic
cells were analyzed by FACS analysis. One-way analysis of variance (ANOVA) with Tukey post hoc comparisons of groups was used to test for
significant effects. The mean is plotted and the error bars represent 95% CI (lower/upper limit). ***, statistically different from control
cells (p < 0.001).
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protein level of PRTG was increased by co-treatment
of miR-9 inhibitor (Figure 4B) and decreased by co-
introduction of miR-9 (Figure 4C). The total cell number
of rabbit articular chondrocytes and human articular
chondrocytes was decreased with IL-1β treatment. A more
significant decrease was observed with co-treatment of
miR-9 or PRTG (Figure 4D).
For further investigation of involvement of miR-9 or
PRTG, macroscopically normal human cartilage from 10
adult donors from both genders (mean age 37.4 years;
age range 20–60 years), without history of joint disease was
confirmed that the specimens were histological normal car-
tilage and used for isolating primary articular chondrocytes.
A significant degenerative phenotype was observed with
IL-1β-treated or PRTG-introduced chondrocytes (Figure 4E
left panel). Most significant degeneration was observed in
the combination of IL-1β and PRTG-treated cell or in the
combination of IL-1β and miR-9 inhibitor-treated cell.
However, IL-1β-induced degeneration was significantly
blocked by co-introduction of miR-9. We also observedthat increased apoptotic cell death by IL-1β was blocked
by co-introduction of miR-9 (Figure 4E right panel). In
addition, co-introduction of PRTG or inhibition of miR-9
significantly increased apoptosis in cells treated with TGF-
β3 (Figure 4F), a known positive regulator of chondrocytes
[27]. For further validation for apoptotic involvement of
miR-9 and PRTG, normal chondrocytes were introduced
with miR-9 in the absence or presence of IL-1β or PRTG
and expression levels of genes involved in apoptosis was
examined (Figure 5). Apoptotic genes including ABL1,
ATP6V1GNOL3, CASP1, 3, 7, CD40, CYLD, and FAS were
induced with IL-1β treatments or PRTG over-expression
whereas expression levels of those genes were decreased
with miR-9 introduction.
MiR-9 also involves in the pathogenesis of osteoarthritis
To investigate the pathological involvement of miR-9, 10
osteoarthritic (OA) cartilage was obtained from patients
diagnosed with OA according to the American College
of Rheumatology (ACR) criteria, which underwent joint
surgery (mean age 64.6 years; age range 52–71 years).
Figure 3 PRTG induced apoptotic death of chondroprogenitors. (A) Cells were electroporated with PRTG/pCAGGS (PRTG) construct in the
absence or presence of miR-9 precursor (miR-9) and electroporation efficiency was confirmed by immunoblotting (left upper panel). Precartilage
condensation and chondrogenic differentiation were analyzed by PA staining at day 3 and Alcian blue staining at day 5 of culture, respectively
(left lower panel) and chondrogenesis was quantified by measuring the absorbance of bound Alcian blue at 600 nm at day3 and day5 of culture
(right panel). (B) Cells were electroporated with PRTG construct and the number of viable cells was determined at 1, 2, and 3 day of culture (left
panel), treated with JNK inhibitor or miR-9, electroporated with PRTG or PRTG siRNA, or in the combination of JNK inhibitor and PRTG siRNA or
PRTG and miR-9 and the number of viable cells were determined at day 2 and 3 of culture (right panel). (C) Apoptotic cells were analyzed by
FACS analysis (left panel) and changes in the cleaved form of caspase-3 were analyzed by Western blotting (right panel). (D) Cells were treated
with JNK inhibitor in the combination of miR-9 or PRTG-specific siRNA, or introduced with miR-9 in the combination of PRTG. Precartilage
condensation and chondrogenic differentiation were analyzed by PA staining at day 3. The diameter of typical standard culture is 5 mm. (E) HH
stage 18 chick embryos (wing bud) were treated with JNK inhibitor in the presence or absence of miR-9 precursor and incubated for additional 2
days (HH stage23). The number of embryos used for each experiment is represented as a table (upper panel), and a representative image of each
limb is shown (lower panel). The mean is plotted and the error bars represent 95% CI (lower/upper limit). *, statistically different from control cells
(p < 0.001).
Song et al. Cell Communication and Signaling 2013, 11:66 Page 5 of 13
http://www.biosignaling.com/content/11/1/66Knee radiographs from the OA participants were classified
as grade IV according to the Kellgren and Lawrence (K/L)
scoring system (Figure 6A). OA cartilage was divided into
non-OA region (A), mild-OA region (B), and severe-OA
region (C, Figure 6A upper panel) as confirmed by a
degenerative morphology with OA progression (Figure 6A
middle panel) and staining with Safranin O and Alcian
blue (Figure 6A lower panel).
Proteolytic degradation of cartilage is a hallmark of OA
and activated chondrocytes are known to produce matrix-
degrading enzymes such as collagenase 3 (MMP-13) in OA
joints [28]. Expression of MMP-13 in mice resulted in
pathologic changes in the joints, similar to human OA
[28]. In addition, the proinflammatory cytokine interleukin-
1 (IL-1β) and MMP-13 localize to the site of cartilage deg-
radation in OA joints, providing evidence of their key
roles in the pathogenesis of OA [29,30]. Consistent with
previous reports [28,30], the expression levels of MMP-2,−12, and −13 (Figure 6B) were increased. Furthermore,
cell viability was significantly decreased in area C and the
caspase-3 activity was significantly increased in area B
and C (Figure 6C). The protein and RNA levels of type
II collagen and miR-9 were decreased whereas those
levels of PRTG were increased as the progression of cartil-
age damage (Figure 6D).
To validate the role of miR-9 in chondrocyte apoptosis
during OA cartilage destruction in vivo, we overexpressed
miR-9 in cartilage tissue by injecting miR-9-expressing or
si-miR-9 expressing lentiviruses into DMM mouse knee
joints (Figure 6E). Cartilage destruction as visualized by
safranin-O staining was significantly induced by DMM
surgery. Semi-quantitative scoring for cartilage destruction
[31] using safranin-O photomicrographs of medial femoral
condyle (MFC) and medial tibial plateau (MTP) indicated
that DMM surgery scored as 0.5 by MFC view and 2 by
MTP view. Most severe cartilage destruction was observed
Figure 5 miR-9 and its target, PRTG is involved in chondrocyte apoptosis. Human articular chondrocytes isolated from biopsy normal
cartilage were electroporated with Prtg or miR-9 in the absence or presence of IL-1β and expression levels of apoptotic genes were examined
and represented as heat-map.
Figure 4 miR-9 is also involved in the degeneration of articular chondrocytes. (A) Rabbit articular chondrocytes were treated with 5 nM IL-
1β in the absence or presence of 100 nM of the miR-9 inhibitor. Change in expression level of miR-9 in was analyzed by real-time PCR. (B)
Images of the cultures were captured using light microscopy (Upper panel). Changes in the protein level of Type II collagen and PRTG during
chondrogenesis were analyzed by Western blotting (Lower panel). GAPDH was used as control. (C) Rabbit articular chondrocytes were treated
with 5 nM IL-1β in the absence or presence of miR-9 precursor. Images of the cultures were captured using light microscopy (Upper panel).
Changes in the protein level of Type II collagen and PRTG during chondrogenesis were analyzed by Western blotting (Lower panel). GAPDH was
used as control. (D) Rabbit and human articular chondrocytes were treated with 5 nM IL-1β in the presence of 100 nM of the miR-9 inhibitor or
the PRTG construct. The number of viable cells was determined at 2 day of culture. (E) Human articular chondrocytes were electroporated with
PRTG, miR-9 inhibitor, or miR-9 in the absence or presence of IL-1β (left panel) and apoptotic cell death (right panel) was analyzed. (F) Human
articular chondrocytes isolated from biopsy normal cartilage were electroporated with Prtg or miR-9 inhibitor in the presence of TGF-β3 and
apoptotic cell death was analyzed. Change in expression level of miR-9 in was analyzed by real-time PCR. *, statistically different from control cells
(p < 0.001). The error bars represent average of data from each human sample. Scale bar, 200 μm.
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Figure 6 MiR-9 is involved in pathogenesis of OA. Articular chondrocytes were isolated form cartilage (upper panel) that was divided
into 3 classes depending on the progression of OA pathology (A: healthy zone, B: intermediate zone, and C: severe zone). (A) Images of the
cultures were captured using light microscopy and human cartilages were stained with safranin O and Alcian blue. (B) The expressions of
MMP-2, MMP-9, MMP-12, and MMP-13 were measured with real-time PCR. (C) Cell viability (right panel) and caspase-3/7 activity (left panel)
were analyzed. (D) Changes in the protein level of Type II collagen and PRTG were analyzed by Western blotting. GAPDH was used as
control (upper left panel). PRTG expression was analyzed by immunocytochemisty (upper right panel). The expressions of type II collagen
(Col II), PRTG, and miR-9 were analyzed by real-time PCR (lower panel). (E) Mouse cartilages with OA induced by destabilization of the
medial meniscus (DMM), were infected with miR-9 or si-miR-9 lentiviruses and stained with safranin O, propium iodide, and Tunnel. PRTG
level was analyzed by immunohistochemistry (left panel). Inserted number in safranin-O photomicrographs indicated the averages of
semi-quantitative score for the degree of cartilage destruction in MFC (first score) and MTP (second score) view. Each histological score for
the degree of cartilage destruction (n = 5 mice/group) in MFC (first score) and MTP (second score) view were graphed (right panel). Sham-
operated (Sham) cartilage was used as control. *, statistically different from control cells (p < 0.001). The error bars represent average of data
from each human sample. Scale bar, 200 μm.
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score of 3, MTP score of 3). However, over-expression of
miR-9 significantly reduced cartilage destruction (MFC
score of 0, MTP score of 0.5). Consistent with this,
increased apoptosis of articular chondrocytes and PRTG
level by DMM surgery was also inhibited with over-
expression of miR-9 and stimulated with suppression of
miR-9.
Discussion
During development, most of our bones form through
endochondral ossification in which bones are first laid
down as cartilage precursor [1] and mitogen-activated pro-
tein kinase (MAPK) cascades are known to play essentialroles in regulating mesenchymal cell chondrogenesis [2,3].
Particularly, our recent study showed the involvement of
JNK signaling during chondrogenesis of limb mesenchymal
cells [11]. We reported the involvement of several miRNAs
including miR-34a [9,10] and miR-221 [11] in JNK-
regulated chondrogenic differentiation. Here, we found
another miRNA, miR-9 involved in JNK-induced chondro-
genic differentiation. Furthermore, we suggested that
miR-9 is one of important players in OA pathogenesis.
MiRNAs play key roles in diverse regulatory pathways,
including cell proliferation, differentiation, apoptosis,
and many other physiological and pathological processes
[32,33]. However, the precise roles of miRNAs in cartilage
biology are largely unknown. Here, we investigated the
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ossification and OA pathogenesis.
MiR-9 provides a model for controlling the balance
between neural stem cell proliferation and differentiation
[34]. MiR-9 is known as a growth inhibition factor and
plays a role as in anti-proliferative activity in human gastric
adenocarcinoma cells by negatively targeting NF-κB1 at
the post-transcriptional level [35]. Jones and colleagues
(2009) suggest the involvement of miR-9 in OA bone and
cartilage by mediating the IL-1β-induced production of
TNF-α [36]. Here, we show that miR-9 targets PRTG,
thus revealing a potential mechanism for apoptotic death
of limb chondroblasts during endochondral ossification.
Experimental evidence indicates that PRTG is a target
of miR-9. First, the ability of miR-9 to regulate PRTG
expression is likely direct, because it binds to the
3′UTR of PRTG mRNA. Second, the luciferase intensity
of PRTG-UTR was specifically responsive to miR-9 over-
expression suggesting that miR-9 may regulate PRTG
protein expression by inducing translational suppression.
Consistent with the results obtained with PRTG over-
expression, knock-down of miR-9 promoted the apoptotic
death of limb chondroblasts. Our study provides evidence
for the mechanism through which miR-9 affects the
survival/proliferation of chondrocytes and PRTG is one of
the physiologic targets of miR-9 in the regulation of chon-
drocyte survival.
In this study, we also sought to determine the effect of
PRTG in chondrogenic differentiation and the regulatory
mechanism of PRTG, a member of the immunoglobulin
superfamily that is most closely related to DCC-Neogenin
subclass [37]. The ability of Neogenin to regulate cell death
appears to be dependent on the context of its expression,
i.e. certain cell types respond differently to cell death sig-
naling. Over-expression of Neogenin in chick dorsal root
ganglion neurons has no noticeable effect on cell survival
[37], whereas in PC12 cells, Neogenin induces apoptosis
[38]. Knockdown of Neogenin in zebrafish increased
apoptotic cell death and reduces neuronal differentiation
[39]. Our results revealed for the first time that PRTG
exerts chondro-inhibitory effects through up-regulation of
apoptotic cell death on limb chondroblasts.
Here, we also suggest the involvement of miR-9 in OA
pathogenesis as well as chondrogenic differentiation of
limb mesenchymal cells. OA is a progressive degenerative
disease characterized by cartilage degradation and chon-
drocyte apoptosis. In addition, chondrocyte apoptosis in
osteoarthritic cartilage has been reported in dogs, humans,
and horses [40,41] and is considered to be one of the major
factors in the pathogenesis of the OA disease process.
Here, we also found that cell viability was decreased in
degenerated rabbit and human articular chondrocytes and
miR-9: PRTG interplay is involved in the apoptotic
process of IL-1β-induced degeneration. It has beenshown that miR-9 is responsible for regulating viability
of chondrocytes and reduction of miR-9 was observed
in generative chondrocytes and this could be a reason
for decreasing cell viability.
The primary pathogenic events in OA include loss and
abnormal remodeling of cartilage extracellular matrix.
Chondrocytes are the major cell type of the articular
cartilage and function to maintain tissue homeostasis.
Recent findings indicate that chondrocyte death and sur-
vival are closely linked with cartilage matrix integrity
[42]. Two key targets of cartilage degeneration during OA
are type II collagen and aggrecan [43]. The accumulation
of degraded fragments over time increase MMP-13
synthesis and leads to positive feedback loop through
interaction with cell-surface integrins resulting destruction
of knee joints [44]. Yang and collegues (1997) found
increased chondrocyte apoptosis in transgenic mice
lacking type II collagen [45]. Our laboratory (2010) also
showed that degradation of type I collagen by MMP-9
stimulated cell death, by interfering with cell attachment
and integrin-mediated survival signaling [46]. These previ-
ous reports suggest that degradation of cartilage matrix
could be an inducer for chondrocyte apoptosis. However,
it still remains unclear whether chondrocyte apoptosis
is a cause of, or the result of, cartilage matrix breakdown.
Cells require attachment to the extracellular matrix (ECM)
for survival, function, and growth. A disruption of the
collagen network could disturb chondrocyte anchorage to
the ECM and result in chondrocyte apoptosis. Alternatively,
cartilage homeostasis could not be maintained due to
chondrocytes apoptosis, and therefore cartilage degrad-
ation could be induced.
We observed an increased protein level of MMP-13, a
major cartilage degrading enzyme, with increasing stages
of OA pathogenesis. In OA, a progressive degenerative
disease, proteolytic degradation of cartilage by matrix-
degrading enzymes, such as MMP-13 [47,48] and
ADAMTS5 [49,50], is a hallmark. MiR-146a functions
in an anti-catabolic manner in articular cartilage by
antagonizing the IL-1β-induced expression of cartilage-
degrading enzymes MMP13 [51] and ADAMTS5 [52].
Reduced miR-140 expression was observed in human OA
cartilage [53,54]. MiR-140 plays dual roles in both cartilage
development and homeostasis, in part via by regulating
Adamts-5 in OA [55]. Our laboratory is currently undergo-
ing study on the relationships between miR-9, PRTG,
and MMP-13 to verify whether chondrocyte apoptosis by
PRTG, a target for miR-9, is down-stream, up-stream, or
independent of MMP-13 induction.
In sum, here, for the first time, we found that PRTG
is regulated by miR-9, resulting in an inhibition of cell
proliferation and survival in chondrogenic progenitors
and articular chondrocytes. Reduction of miR-9 induction,
which results in increased PRTG levels in OA pathogenesis,
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Mesenchymal cells (at a density of 2 × 107 cells/ml) were
derived from the distal tips of Hamburger-Hamilton
(HH) stage 22/23 embryo limb buds of fertilized White
Leghorn chicken eggs or E11.5 embryos. They were
micromass cultured in Ham’s F-12 medium containing
10% fetal bovine serum (FBS), 100 IU/ml penicillin, and
100 μg/ml streptomycin (Gibco Invitrogen, Grand Island,
NY). A concentration of 5 μM was chosen for JNK inhibi-
tor II (Calbiochem, San Diego, CA) and treated for entire
culture period in this study.
Rabbit articular chondrocytes from joint cartilage slices
of 2-week-old New Zealand white rabbits were isolated
with 0.2% collagenase type II, as described previously
[56] and were then plated on culture dishes at a density
of 5 × 104 cells/cm2. The medium was replaced every
2 days after seeding.
Human articular cartilage specimens were obtained
from cartilages that were undergoing total knee arthro-
plasty. Tissue collection was approved by the Human Sub-
jects Committee of Wonkwang University. Chondrocytes
were extracted as previously described [57] and seeded
at a density of 1.5 × 104 cells/cm2 in DMEM (Gibco-
Invitrogen) supplemented with 10% fetal bovine serum
(FBS), 100 units/ml penicillin, and 100 μg/ml strepto-
mycin (Gibco Invitrogen). A concentration of 5 ng/ml was
chosen for IL-1β (R & D systems, Minneapolis, MN) in
this study.
Analysis of cell differentiation and precartilage
condensation
Alcian blue bound to sulfated glycosaminoglycans was
extracted with 6 M guanidine-HCl, and quantified by
measuring the absorbance of the extracts at 600 nm.
Cultures were incubated with 100 μg/ml biotinylated
peanut agglutinin (PA, Sigma) and visualized with the
VECTASTAIN ABC and DAB substrate solution kit
(Vector laboratories Inc., Burlingame, CA).
Apoptosis assay
Apoptosis was analyzed by a flow cytometer (FACS
calibure, Becton-Dickinson, France). To detect extent of
propidium iodide, cells were excited at 488 nm and
emission was observed at 585 nm.
Caspase assay
Activities of caspase-3 and caspase-7 were determined
using a caspase colorimetric assay kit (R&D Systems Inc.,
Minneapolis, MN, USA).Cell viability assay
Cell viability was assayed using CellTiter-Glo luminescent
cell viability assay kit (Promega), which determines viabil-
ity based on the quantification of ATP present in metabol-
ically active or viable cells [58].Cell proliferation assay
Proliferation was determined by direct counting of cells.
Control and treated cultures were detached with trypsin/
EDTA solution and counted in triplicate using a
hematocytometer.Western blot analysis
Total proteins (30 μg) were electrophoresed and trans-
ferred to nitrocellulose membranes (Schleicher and
Schuell, Keene, Germany). The membranes were indi-
vidually probed with antibodies specific for Type I, II
collagen, PRTG (Calbiochem, La Jolla, CA), (p)AKT,
(p)GSK, (p)JNK, GAPDH (Santa Cruz Biotechnology
Inc.), Caspase-3, PARP (Cell Signaling Technology Inc.,
Danvers, MA, USA). The blots were developed using a
peroxidase-conjugated secondary antibody, and the
immunoreactive proteins were visualized with an ECL
system (Amersham, UK).Electroporation
Chondrogenic progenitors were electroporated with either
a myc-tagged PRTG (PRTG) expression vector (a kind gift
from Dr. D. Watanabe at Department of Molecular
Neurobiology, Institute of Development, Aging and
Cancer, Tohoku University, Japan; pCAGGS was used
as mock) or PRTG-specific siRNA (purchased from
Invitrogen, PRTG_stealth primers; 5′-UUUACAGGUAA
AUCGAGCUACUCCA-3′, 5′-UGGAGU AGCUCGAU
UUACCUGUAAAA-3′) using a BTX-830 square wave
generator (Gentronics, San Diego, CA) with 20 msec,
200 square pulses.MiRNA and mRNA real-time quantitative RT-PCR
MiRNA and mRNA expression were independently quan-
tified using the TaqMan MicroRNA and TaqMan gene
expression assays (Applied Biosystems), respectively, ac-
cording to the manufacturer’s protocols. MiRNA ex-
pression was normalized to RNU43 small nuclear RNA
endogenous controls.
For mRNA, transcripts were quantified by real-time
quantitative polymerase chain reaction (RT-PCR) and
normalized to the amount of GAPDH mRNA expressed
The oligonucleotides used as primers were listed in
Table 1.
Table 1 The list of primers
Mouse gene Primers
PRTG 5′-aagtcaatgacgggcatcgcagta-3′ 5′-acttcctggcttgcttcggtaga-3′
Type X collagen 5′-ataagaacggcacgcctaagatgt-3′ 5′-ctgcattgggcattggagccata-3′
GAPDH 5′-tgtccgtcgtggatctgac-3′ 5′-cctgcttcaccaccttcttg-3′
Human gene Primers
type II collagen 5′-tcactcatgccctgaag-3′ 5′-ctatgtccatgggtgcaatg-3′
PRTG 5′-tgcatgcaagat tcatcccaccc-3′ 5′-tgcaatactcctgttggtagggca-3′






APP 5′-tgtccgcgc agaacagaa-3′ 5′-tgtccgcgcagaacagaa-3′
ATP6V1G2 5′-ggaaaacatcctgacttcagtgtct-3′ 5′-ccagcaagtgacagggtcaa-3′
BAX 5′-ccaaggtgccgg aactga-3′ 5′-cccggaggaagtccaatgt-3′
BCL2A1 5′-cctggatcaggtccaagcaa-3′ 5′-ttggactgagaacgcaacattt-3′
BCL2L11 5′-gctttcccatggtcacaggat-3′ 5′-ctgcagctggactctgctgta-3′
BIRC2 5′-cctgtggtgggaagctcagt-3′ 5′-cctccg gtgttctgacatagc-3′
CASP1 5′-at accaagaactgcccaagtttg-3′ 5′-ggcaggcctggatgatga-3′
CASP2 5′-ggtaaagaaaagttgccgaagatc-3′ 5′-ggcatag ccgcatatcatgtc-3′







CYLD 5′-tgtggagggcttgcaatgt-3′ 5′-agctgagatgtcc ggatcgt-3′
DEFB1 5′-ttgacgctccctgctcaga-3′ 5′-tggacggtggcacaactct-3′
FAS 5′-acccgctcagtacggagttg-3′ 5′-ccagcatggttgtt gagcaa-3′
FASLG 5′-tgcctcctcttgagcagtca-3′ 5′-tcctgtagaggctgaggtgtca-3′
GADD45A 5′-gatgtggctctgcagatcca-3′ 5′-atgtcgttctcgc agcaaaa-3′
IGF1R 5′-cttgtacattcgca ccaatgct-3′ 5′-cgattaactgagaagaggagttcga-3′
NOL3 5′-gcccaccacgagcatca-3′ 5′-cctggactcctaag ggcagat-3′
TNF 5′-gcccaccacgagcatca-3′ 5′-cctggactcctaag ggcagat-3′
TP53 5′-tgcaataggtgtgcgtcagaa-3′ 5′-ccccg ggacaaagcaaa-3′
GAPDH 5′-gatcatcagcaatgcctcct-3′ 5′-tgtggtcatgagtccttcca-3′
ABL1 c-abl oncogene1, non receptor tyrosine kinase, AFAF1 apoptotic peptidase activating factor1, APP amyloid beta-A4 pre cursor protein, ATP6V1G2
ATPase, H + transporting lysosomal 13 kDa, V1 subunit G2, BAX BCL2-associated × protein, BCL2A1 BCL2-related protein A1, BCL2L1 BCL2-like 1, BCL2L11
BCL2-like 11, B, IRC2 baculoviral IAP repeat containing 2, CASP1 caspase 1- apoptosis-related cysteine peptidase, CASP3 caspase 3- apoptosis-related
cysteine peptidase, CASP9 caspase 9- apoptosis-related cysteine peptidase, CD40 CD40 molecule, TNF receptor super family member 5, CD40LG CD40
ligand, CFLAR CASP8 and FADD-like apoptosis regulator, CYLD cylindromatosis-turban tumor syndrome, DEFB1 defensin, beta 1, DFFA DNA
fragmentation factor, 45 kDa, alpha polypeptide, FAS Fas-TNF receptor super family, member 6, FASLG Fas ligand-TNF super family, member 6, GADD45A
growth arrest and DNA-damage-inclucible, alpha, IGF1R insulin-like growth factor 1 receptor, NOL3 necleolar protein 3-apoptosis repressor with CARD
domain, TNF tumor necrosis factor, TP53 tumor protein p53.
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inhibitor and induction in cells
PNA, an artificially created DNA analogue, exhibits super-
ior binding affinity and chemical/biological stability because
the phosphate ribose ring of DNA is replaced with a
polyamide backbone. The PNA-based ASOs, which
contain an O-linker at the N terminus of the PNA to
improve solubility, were purchased from Panagene (Korea).
A scrambled PNA-based ASO was used as a negative
control (5′-RRRQRRKKR-00-ATTAATGT CGGACAA-3′,
RRRQRRKKR: cell penetrating peptide; O:AEEA linker)
and 200 nM of PNA-based ASO (PNA9: UCUUUGGUU
AUCUAGCUGUAUGA) were electroporated into isolated
mesenchymal cells.Reporter vectors and DNA constructs
The 3′-UTR of human PRTG (PRTG) was PCR amplified
using the following primers: 5′-TGGGAGCTCCTGGCT
CTATT-3′ (bp no. 1616 ~ 1635), 5′-GCTGAGGCTGAC
TTT GCACT-3′ (bp no. 3088 ~ 3107). It was then cloned
downstream of the CMV-driven firefly luciferase cassette
in the pMIR-REPORT vector (Ambion). For miRNA
target validation, chondroblasts were electroporated
with 200 ng of a firefly luciferase reporter construct, 50
pmol of pre-miR-9 or pre-miR-negative (Ambion). The
Renilla luciferase vector was used to normalize electropor-
ation efficiency. At 24 hr after electroporation, both firefly
and Renilla luciferase activity were assayed (Promega).
Normalized relative light units represent firefly luciferase
activity or Renillar luciferase activity.Arthritic cartilage, experimental OA, and histology
of OA cartilage
International Cartilage Repair Society (ICRS) grade 10
human OA cartilage was sourced from individuals (age
51–72 years) undergoing arthroplasty for OA of the
knee joint. The Wonkwang University Hospital Institu-
tional Review Board approved the use of these mate-
rials, and all individuals provided written informed
consent before the operative procedure. Human OA
cartilage samples were frozen, sectioned at a thickness
of 10 μm, fixed in paraformaldehyde, and stained with
Alcian blue.
Experimental OA was induced by destabilization of
the medial meniscus (DMM) surgery 8-week-old male
mice. Sham-operated animals injected with empty lentivi-
ruses (mock transduction) were used as controls for
DMM. Mice were killed 8 weeks after DMM surgery or
2 weeks after intraarticular injection (1 × 109 plaque-
forming units (PFU)) of miR-9-expressing lentiviruses
(lenti-miR-9) for histological and biochemical analyses.
Cartilage destruction in mice was examined using Safranin
O staining. Briefly, knee joints were fixed in 4%paraformaldehyde, decalcified in 0.5 M EDTA (pH 7.4) for
14 days at 4°C, and embedded in paraffin. The paraffin
blocks were sectioned at 6 μm thickness. The sections
were deparaffinized in xylene, hydrated with graded
ethanol, and stained with Safranin O.
Tunnel assay
Apoptosis of articular chondrocytes in cartilage tissues
was determined by TUNEL assay using a kit from Clontech
(Mountain View, CA). Specimens were visualized under a
fluorescence microscope.
Immunohistochemistry
Deparaffinized section was incubated with the anti-PRTG
antibody (1: 200 dilutions) overnight at 4°C, followed by
incubation with rhodamine-conjugated secondary antibody
at room temperature for 1 hour. Specimens were visualized
under a fluorescence microscope.
Statistical analysis
Statistical analysis was performed using the SPSS program
for Windows, Standard Version (version 18.0, SPSS Inc.,
Chicago, http://www.SPSS.com).
Additional file
Additional file 1: Differentially expressed miRNAs at 48 hr after
suppression of JNK signaling in limb mesenchymal cells.
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